Clinical Trial Update: Growth Hormone in Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating growth hormone (somatropin) in amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Federico II University | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED